Prescription drug · ANDA
Fluorouracil NDC 63323-117
Fluorouracil 50 mg/mL · Injection, Solution · Intravenous · Fresenius Kabi USA, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63323-117-10 | 6332301171063323011710 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-117-10) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-117-00)Marketed from Jan 2, 2017 | |
| 63323-117-20 | 6332301172063323011720 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-117-20) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-117-01)Marketed from Jan 2, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Fluorouracil
- Generic name (nonproprietary)
- fluorouracil
- Active ingredients
- Fluorouracil — 50 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Fresenius Kabi USA, LLCNDC labeler code 63323
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040279
- Marketing start
- Listing expires
- Other FDA classes
- Nucleic Acid Synthesis Inhibitors (Mechanism)
- Identifiers
- Product ID 63323-117_0c579d19-82e7-4aac-bcb6-b3a60a3b48a3SPL ID 0c579d19-82e7-4aac-bcb6-b3a60a3b48a3SPL set ID c45f5286-a52b-43e5-8a6f-d0312e7da0c8RxCUI 239177, 1791701, 1791736UNII U3P01618RTUPC 0363323117016, 0363323117009
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N463323011710followed by a unit qualifier and the quantityPackage 63323-0117-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Fluorouracil is indicated for the treatment of patients with: Fluorouracil is a nucleoside metabolic inhibitor indicated for the treatment of patients with • Adenocarcinoma of the Colon and Rectum ( 1.1 ) • Adenocarcinoma of the Breast ( 1.2 ) • Gastric Adenocarcinoma ( 1.3 ) • Pancreatic Adenocarcinoma ( 1.4 ) 1.1 Adenocarcinoma of the Colon and Rectum 1.2 Adenocarcinoma of the Breast 1.3 Gastric Adenocarcinoma 1.4 Pancreatic Adenocarcinoma
Excerpt only. Read the full label for complete information.
About NDC 63323-117
- What is NDC 63323-117?
- 63323-117 is the product NDC for Fluorouracil, Fluorouracil 50 mg/mL injection, solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Fluorouracil.
- What is the active ingredient?
- Fluorouracil.
- Who is the labeler?
- Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Fluorouracil?
- 40 other product NDCs are listed under this name. See all Fluorouracil NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Fluorouracil products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-972 | 23155-0972-41 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-973 | 23155-0973-41 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-974 | 23155-0974-31 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-975 | 23155-0975-31 |
| Fluorouracilfluorouracil cream, 0.5% | Fluorouracil 5 mg/g | CreamTopical | Dr. Reddy's Laboratories Inc. | 75907-169 | 75907-0169-11 |
| Fluorouracil | Fluorouracil 2 g/40g | CreamTopical | Encube Ethicals, Inc. | 21922-049 | 21922-0049-17 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-154 | 71288-0154-76 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | BluePoint Laboratories | 68001-628 | 68001-0628-32 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | BluePoint Laboratories | 68001-627 | 68001-0627-27 |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-170 | 71288-0170-75 |
Other NDCs under ANDA 040279
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | ProPharma Distribution | 84549-117 |